Condition
Axillary Lymph Nodes
Total Trials
3
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Recruiting1
Not Yet Recruiting1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT03796559Not ApplicableRecruiting
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
NCT06903429Not ApplicableNot Yet Recruiting
Using LUminoMark vs Coventional Practice for Targeted Axillary Surgery
NCT02800317Not ApplicableCompleted
RISAS Procedure in Node Positive Breast Cancer Following NAC
Showing all 3 trials